Periprocedural antiplatelet medication assessed by VerifyNow for neuroendovascular treatment: Comparison of prasugrel with clopidogrel

CONCLUSIONS: Maintenance dose PRAS further decreased the PRU value and reached the optimal range in more cases than CLP during the perioperative period of neuroendovascular treatment. Ischemic complications significantly increased in the 208 < PRU group.PMID:38082549 | DOI:10.1177/15910199231219019

Source: Interventional Neuroradiology - December 12, 2023 Category: Radiology Authors: Kosuke Nambu Kouichi Misaki Takehiro Uno Taishi Tsutsui Tomoya Kamide Mitsutoshi Nakada Source Type: research